Suppr超能文献

[原发性慢性肾小球肾炎的当前治疗可能性]

[Present possibilities of treatment of primary chronic glomerulonephritis].

作者信息

Knotková V, Nĕmecek K

机构信息

II. interní klinika 1. LF UK, Praha.

出版信息

Vnitr Lek. 1994 Jun;40(6):345-8.

PMID:8073642
Abstract

The authors evaluate in a retrospective study the effect of prednisone, cyclophosphamide, small doses of acetylsalicylic acid, conventional antihypertensive drugs and ACE inhibitors on the course of primary chronic proliferative types of glomerulonephritis. The group comprised 44 patients, incl. 16 with normal blood pressure and 28 with hypertension. All were at first given prednisone and cyclophosphamide--for an average of 18 months--and the patients with systemic hypertension conventional antihypertensive drugs. At the termination of treatment proteinuria in the whole group was significantly lower, while glomerular filtration was unaltered, i.e. normal. When the results in normotonic and hypertonic patients were evaluated separately, it was obvious that normotonic patients have a significantly lower proteinuria and a glomerular filtration significantly higher than hypertonic patients. After termination of immunosuppression the authors started to administer to all patients acetylsalicylic acid (1/4 tablet Anopyrin in 24 hours) and in hypertensive patients the conventional antihypertensive drugs were replaced by ACE inhibitors, combined in some with Ca channel blockers. Antiaggregation therapy persists now for more than three years, treatment with ACE inhibitors for more than two years. The results at the end of the investigation indicate that there is no significant difference between normotonic and hypertonic subjects. All have proteinuria lower than 2.0 g/24 hours, stabilized glomerular filtration and after 15 years of glomerulonephritis none of the patients suffers from chronic renal failure. The authors assume that combined immunosuppression, antiaggregation therapy and treatment of hypertension with ACE inhibitors can contribute to the stabilization of chronic glomerulonephritis.

摘要

作者在一项回顾性研究中评估了泼尼松、环磷酰胺、小剂量乙酰水杨酸、传统抗高血压药物和血管紧张素转换酶抑制剂对原发性慢性增殖型肾小球肾炎病程的影响。该组包括44例患者,其中16例血压正常,28例患有高血压。所有患者最初均接受泼尼松和环磷酰胺治疗,平均治疗18个月,患有系统性高血压的患者则接受传统抗高血压药物治疗。治疗结束时,全组蛋白尿显著降低,而肾小球滤过率未改变,即正常。当分别评估血压正常和高血压患者的结果时,明显发现血压正常的患者蛋白尿显著低于高血压患者,肾小球滤过率显著高于高血压患者。免疫抑制治疗结束后,作者开始给所有患者服用乙酰水杨酸(24小时服用1/4片安乃近),对于高血压患者,将传统抗高血压药物换成血管紧张素转换酶抑制剂,部分患者联合使用钙通道阻滞剂。抗聚集治疗目前已持续三年多,血管紧张素转换酶抑制剂治疗已持续两年多。研究结束时的结果表明,血压正常和高血压患者之间没有显著差异。所有患者的蛋白尿均低于2.0g/24小时,肾小球滤过率稳定,肾小球肾炎发病15年后,没有患者出现慢性肾衰竭。作者认为,联合免疫抑制、抗聚集治疗以及使用血管紧张素转换酶抑制剂治疗高血压有助于稳定慢性肾小球肾炎。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验